MicroPort Endovascular MedTech Ltd (688016) — Capital Reinvestment Ratio
Latest as of September 2025:
1.84x
MicroPort Endovascular MedTech Ltd (688016) has a Capital Reinvestment Ratio of 1.84x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥46.79 Million) in capital expenditures (CN¥86.03 Million). See 688016 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.84x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥46.79 Million
CNY
Capital Expenditures
CN¥86.03 Million
CNY
Data as of
Sep 2025
Most recent filing
MicroPort Endovascular MedTech Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks MicroPort Endovascular MedTech Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for MicroPort Endovascular MedTech Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for MicroPort Endovascular MedTech Ltd from 2016 to 2025. For live market cap and broader valuation context, see 688016 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | CN¥573.06 Million | CN¥303.03 Million | ▼ -7.1% |
| 2024 | 0.57x | CN¥373.60 Million | CN¥212.65 Million | ▲ +70.9% |
| 2023 | 0.33x | CN¥571.22 Million | CN¥190.26 Million | ▼ -62.2% |
| 2022 | 0.88x | CN¥333.76 Million | CN¥293.98 Million | ▲ +195.2% |
| 2021 | 0.30x | CN¥300.25 Million | CN¥89.58 Million | ▲ +147.4% |
| 2020 | 0.12x | CN¥217.44 Million | CN¥26.22 Million | ▼ -18.7% |
| 2019 | 0.15x | CN¥143.20 Million | CN¥21.24 Million | ▼ -36.4% |
| 2018 | 0.23x | CN¥106.85 Million | CN¥24.90 Million | ▼ -42.7% |
| 2017 | 0.41x | CN¥69.36 Million | CN¥28.23 Million | ▼ -61.4% |
| 2016 | 1.06x | CN¥30.13 Million | CN¥31.81 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow